高 雅慧

Medicine & Life Sciences

1. Databases 30%
2. Stroke 28%
3. Cohort Studies 25%
4. Population 21%
5. Antipsychotic Agents 17%
6. Pharmaceutical Preparations 14%
7. Cerebral Hemorrhage 13%
8. Venous Thromboembolism 13%
9. Retrospective Studies 12%
10. Hydroxymethylglutaryl-CoA Reductase Inhibitors 12%
11. Incidence 12%
12. Confidence Intervals 10%
13. Drug-Related Side Effects and Adverse Reactions 10%
14. Allopurinol 10%
15. Elderly 9%
16. Sequence Analysis 9%
17. Osteoporosis 9%
18. Myocardial Infarction 8%
19. Hospitalization 8%
20. Therapeutics 8%
21. Pharmacists 8%
22. Sulpiride 8%
23. Korea 7%
24. Sodium-Glucose Transporter 2 Inhibitors 7%
25. Phenytoin 7%
26. Symporters 7%
27. Risperidone 7%
28. Safety 6%
29. Hip Fractures 6%
30. Propensity Score 6%
31. Mortality 6%
32. Raloxifene Hydrochloride 6%
33. Haloperidol 6%
34. Aspirin 6%
35. Pharmacoepidemiology 6%
36. Electronic Health Records 6%
37. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 6%
38. Anticonvulsants 5%